Search

everythinglearnresearchcommunity

for

Search:↓

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Immunoadsorption successfully treated a man's resistant polymyositis.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Tadalafil and Finasteride may help treat aggressive melanoma.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Finasteride may help treat childhood brain tumors by activating certain genes.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.

Ruxolitinib can help regrow hair in severe alopecia areata.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

The nanocomposite effectively targets lung cancer cells without harming normal cells.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Research on non-muscle invasive bladder cancer has increased, with the U.S. leading, and highlights effective treatments like BCG despite some side effects.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Researchers made new compounds that could potentially be developed into anticancer drugs.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Chemotherapy may help with survival in children with medulloblastoma, but more research is needed.